We need your help to raise $200,000 by midnight tonight so we can fund early-onset bowel cancer research that has the potential to improve survival and help build a path toward a cure.
Bowel cancer is the deadliest cancer and the sixth leading cause of death for Australians aged 25-44.
Bowel Cancer Australia is focused on funding promising, high-impact, early-onset bowel cancer research endeavours to help improve our knowledge and understanding of this disease, including:
the causes of young-onset bowel cancer;
better pathways to diagnosis;
unique needs of younger patients;
new treatment options; and
tailored support and care.
We need answers. Now.
Donate now and have your gift MATCHED, so your donation will have DOUBLE the impact.
Diagnosed with Stage 4c bowel cancer at just 27, Taylor has firsthand experience with how powerful the outcomes of cutting-edge research can be.
"Things looked very bad for a few months, and I was faced with the real possibility of dying.
Luckily, I was eligible for an immunotherapy trial and after just eight months on the trial, my disease was classed as stable! We thought it was the best news we could hope for. But then, my tumours and nodes just kept shrinking!
In May 2022, after 20 rounds and 20 months of immunotherapy, my oncologist gave me the amazing news that I’d had a complete metabolic response to the treatment. I had no evidence of disease!" ~ Taylor.
